Earnings Releases

Alto Neuroscience, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 13, 2026, Alto Neuroscience, Inc. (the “Company”) reported financial results for the fiscal quarter ended March 31, 2026.”

IMMUNIC, INC. reported financial results for first quarter ended March 31, 2026.

“On May 13 2026, Immunic, Inc. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1, announcing the Company’s financial results for the quarter ended March 31, 2026, and providing a corporate update”

Avalo Therapeutics, Inc. reported first quarter 2026 results: net income Net loss was $19.6 million, EPS Basic and diluted net loss per share was $0.98.

“On May 13, 2026, Avalo Therapeutics, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.”

BeyondSpring Inc. reported the quarter ended March 31, 2026 results: net income Net loss was $2.4 million.

“On May 13, 2026, BeyondSpring Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”

VERU INC. reported six months ended March 31, 2026 results: net income $8.1 million, or $0.37 per share, EPS $0.37 per share.

“Net loss decreased to $8.1 million, or $0.37 per share, compared to $16.8 million, or $1.15 per share”

VERU INC. reported fiscal 2026 second quarter ended March 31, 2026 results: net income $2.7 million, or $0.12 per share, EPS $0.12 per share.

“Net loss decreased to $2.7 million, or $0.12 per share, compared to $7.9 million, or $0.54 per share”

Protalix BioTherapeutics, Inc. updated its the first quarter ended March 31, 2026 guidance (reaffirmed).

“Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026”

Eos Energy Enterprises, Inc. reported first quarter ended March 31, 2026 results: revenue $57.0 million, net income $508.9 million. Guidance reaffirmed.

“today announced its financial results for the first quarter ended March 31, 2026. First Quarter Highlights • Revenue totaled $57.0 million”

Aprea Therapeutics, Inc. reported financial results for first quarter ended March 31, 2026.

“On May 13, 2026, Aprea Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026, and provided an update on the Company’s operations for the same period.”

Dynatrace, Inc. reported financial results for the fiscal quarter and year ended March 31, 2026.

“On May 13, 2026, Dynatrace, Inc. (the "Company") issued a press release announcing, and will hold a conference call to discuss, the Company's financial results and other information for the fiscal quarter and year ended March 31, 2026. The full text of the press release is furnished as Exhibit 99.1 to this report and incorporated into this Item 2.02 by reference.”

Castellum, Inc. reported the three months ended March 31, 2026 results: revenue $14.3 million, net income Net loss was $0.4 million, EPS $0.00 per basic and diluted share.

“focused on the federal government, today announced its financial results for the three-month period (“Q1”) ended March 31, 2026. Q1 2026 Financial Highlights • Revenues of $14.3 million, up 23% as compared to $11.7 million in Q1 2025. • Gross profit of $5.1 million, up 11% as compared to $4.6 million in Q1 2025. • Adjusted EBITDA * was $0.4 million, compared to”

COMPASS Pathways plc reported for the three months ended March 31, 2026 results: net income $91.2 million, or $0.71 net income per share (basic) and $0.30 net loss per share (diluted), EPS $0.71 net income per share (basic) and $0.30 net loss per share (diluted). Guidance reaffirmed.

“Compass Pathways plc (the “Company”) issued a press release announcing the Company's financial results for the three months ended March 31, 2026.”

Zenas BioPharma, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 13, 2026, Zenas BioPharma, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026.”

National Vision Holdings, Inc. reported first quarter ended April 4, 2026 results: revenue $543.9 million, net income $31.2 million, EPS $0.38. Guidance reaffirmed.

“Continues to Deliver Stronger Profitability and Earnings Growth Reiterates 2026 Guidance First quarter 2026 highlights compared to first quarter 2025: • Net revenue of $543.9 million, increased 6.6% • Comparable store sales growth of 4.4% and Adjusted Comparable Store Sales Growth of 4.5% • Net income of $31.2 million, Diluted EPS of $0.38, with Net income”

REGIS CORP reported financial results for third fiscal quarter ended March 31, 2026.

“On May 13, 2026, Regis Corporation announced the financial results for its fiscal quarter ended March 31, 2026 . A copy of the Press Release issued by Regis Corporation in connection with this Item 2.02 is attached as Exhibit No. 99.1 and incorporated by reference herein.”

Anteris Technologies Global Corp. reported financial results for first quarter of 2026.

“today reported financial results for the quarter ended 31 March 2026, and provided a corporate update.”

Azitra, Inc. reported the quarter ended March 31, 2026 results: net income $3.9 million.

“Net Loss was $3.9 million for the quarter ended March 31, 2026, compared to $3.1 million for the comparable period in 2025.”

i-80 Gold Corp. reported financial results for the quarter ended March 31, 2026.

“On May 12, 2026, i-80 Gold Corp. issued a press release announcing its financial results for the quarter ended March 31, 2026.”

Grown Rogue International Inc. reported the three months ended March 31, 2026 results: revenue $9.2 million, net income GAAP net loss of $2.2 million. Guidance raised.

“Garden State, LLC ("ABCO"), within the Company's financial statements. Comparative periods have been recast, where applicable, in accordance with GAAP. Highlights: • Revenue of $9.2 million for the first quarter of 2026, compared to $7.2 million in the first quarter of 2025, an increase of approximately 28%, with growth driven largely by material revenue increases”

TECOGEN INC. reported the quarter ended March 31, 2026 results: revenue $6.34 million, net income net loss of $2.12 million, EPS a loss of $0.07 /share.

“Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products, reported revenues of $6.34 million and net loss of $2.12 million for the quarter ended March 31, 2026 compared to revenues of $7.28 million, and a net loss of $0.66 million in 2025.”

FONAR CORP reported the nine-month period ended March 31, 2026 results: revenue $78.1 million, net income $7.5 million, EPS $0.89 per share.

“31, 2026 decreased 3% to $26.5 million as compared to $27.2 million for the quarter ended March 31, 2025. Total Revenues-Net for the nine-month period ended March 31, 2026 was $78.1 million as compared to $77.1 million for the nine-month period ended March 31, 2025. Selling, general & administrative costs (SG&A) increased 5% to $8.4 million for the quarter ended”

FONAR CORP reported the quarter ended March 31, 2026 results: revenue $26.5 million, net income $2.3 million, EPS $0.24 per share.

“Stockholders decreased 35% to $0.24 per share for the quarter ended March 31, 2026 as compared to th e quarter ended March 31, 2025. · Total Revenues-Net decreased 3% to $26.5 million for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. · Total Cash, Cash Equivalents and Short-Term Investments decreased 4% to $53.8 million at”

BridgeBio Oncology Therapeutics, Inc. reported the first quarter ended March 31, 2026 results: net income Net loss was $42.1 million for the first quarter of 2026 compared to $22.1 million for the first qu.

“BridgeBio Oncology Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”

High Roller Technologies, Inc. reported first quarter ended March 31, 2026 results: revenue $3.4 million, net income $3.0 million, EPS ($0.29) per common share.

“underlying business,” continued Young. “Lower operating expenses contributed to improved YoY Adjusted EBITDA while we increased strategic capital allocations. Net revenues of $3.4 million reflected our deliberate exit from certain markets and heavily reduced customer acquisition spend in the online casino vertical. Our operating efficiency strengthened”

DIODES INC /DEL/ reported preliminary financial results for first quarter 2026.

“the Company’s press release dated May 7, 2026, announcing the Company’s first quarter 2026 financial results”

Varagon Capital Corp reported the quarter ended March 31, 2026 results: net income $0.24 per share, EPS $0.03.

“On May 12, 2026, Varagon Capital Corporation released an earnings presentation relating to its financial results for the quarter ended March 31, 2026.”

FRP HOLDINGS, INC. reported financial results for the quarter ended March 31, 2026.

“On May 12, 2026, FRP Holdings, Inc. issued a press release announcing results of operations for the first quarter ended March 31, 2026.”

Bitcoin Depot Inc. reported the three months ended March 31, 2026 results: revenue decreased by $80.7 million, or 49.2%, net income Net loss was $9.5 million.

“of operations for the fiscal quarter ended March 31, 2026 differed significantly from its results of operations for the fiscal quarter ended March 31, 2025. Revenue decreased by $80.7 million, or 49.2%, for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025, primarily due to a decrease in transaction volume driven by a”

Southland Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $172.4 million, net income $28.4 million, EPS $(0.52) per share.

“Revenue of $172.4 million for the quarter ended March 31, 2026, compared to $239.5 million for the quarter ended March 31, 2025.”

SANUWAVE Health, Inc. reported the three months ended March 31, 2026 results: revenue $9.6 million. Guidance reaffirmed.

“Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025.”

Dolphin Entertainment, Inc. reported first quarter ended March 31, 2026 results: revenue $12.8 million, net income $2.7 million, EPS $(0.22). Guidance reaffirmed.

“quarter is historically our lightest due to normal business seasonality, we are pleased to report continued top-line growth, with total revenue increasing 5.2% year-over-year to $12.8 million. Furthermore, we reduced our Adjusted EBITDA loss by 25% year-over-year. We emphasize Adjusted EBITDA because, given our significant non-cash amortization expenses and minimal”

Stran & Company, Inc. reported the first quarter of 2026 ended March 31, 2026 results: revenue $31.2 million, net income $0.7 million.

“Stran & Company Reports $31.2 Million in Revenue and Achieves EBITDA of $1.0 Million for the First Quarter of 2026”

Inhibikase Therapeutics, Inc. reported the quarter ended March 31, 2026 results: net income $16.4 million, or $0.10 per share, EPS $0.10 per share.

“Net loss for the quarter ended March 31, 2026, was $16.4 million, or $0.10 per share, compared to a net loss of $13.7 million, or $0.15 per share in the quarter ended March 31, 2025.”

AMERICAN BATTERY TECHNOLOGY Co reported third quarter of fiscal year 2026 (FY26) ended on March 31, 2026 results: revenue $7.8 million in Revenue.

“capitalize on strong market conditions and solidify itself as one of the dominant critical mineral recyclers in the United States. Financial Highlights, Third Quarter of FY26: ● $7.8 million in Revenue , a 64% increase from the previous quarter ○ And an additional $0.3 million income from interest for the quarter ● $7.1 million in Cost of Goods Sold , an 11%”

Bridger Aerospace Group Holdings, Inc. reported first quarter ended March 31, 2026 results: revenue $8.5 million, net income $(31.3) million, EPS $(0.69). Guidance reaffirmed.

“First quarter 2026 revenue of $8.5 million, in line with guidance as the Company prepares for fire season”

GLADSTONE INVESTMENT CORPORATION\DE reported financial results for fourth quarter and fiscal year ended March 31, 2026.

“On May 12, 2026, Gladstone Investment Corporation issued a press release announcing its financial results for its fourth quarter and fiscal year ended March 31, 2026.”

TRANSACT TECHNOLOGIES INC reported the first quarter ended March 31, 2026 results: revenue $14.4 million, net income $766 thousand, or $0.07 per diluted share. Guidance reaffirmed.

“solutions, today reported preliminary results for the first quarter ended March 31, 2026. “We are pleased to report a solid start to 2026, with first quarter net sales of $14.4 million, up 10% year-over-year, and a return to GAAP profitability,” said John Dillon, Chief Executive Officer of TransAct. “The performance was broad-based, with casino and gaming sales”

AUDIOEYE INC reported the first quarter ended March 31, 2026 results: revenue $10.6M, net income $2.1M, EPS $(0.17) per share. Guidance initiated.

“customers in the future and look forward to increasing the value they receive from our products.” ​ First Quarter 2026 Financial Results ● Total revenue increased 8% to a record $10.6M from $9.7M in the same prior year period. ● Gross profit increased to $8.3M (78% of total revenue) from $7.7M (80% of total revenue) in the same prior year period. The increase”

LB PHARMACEUTICALS INC reported financial results for the first quarter ended on March 31, 2026.

“On May 12, 2026, LB Pharmaceuticals Inc (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”

ASTRONICS CORP reported first quarter 2026 results: revenue $230.6 million, net income $25.5 million, EPS $0.67 per diluted share. Guidance raised.

“Commerce Way • East Aurora, NY • 14052-2164 FOR IMMEDIATE RELEASE Astronics Corporation Reports 12% Sales Growth for First Quarter 2026 • First quarter sales increased 12.0% to $230.6 million • Achieved first quarter net income of $25.5 million, or $0.67 per diluted share; adjusted EBITDA 1 was $37.9 million, or 16.4% of sales • Aerospace operating margin expanded to”

Andersen Group Inc. reported the first quarter ended March 31, 2026 results: revenue $240.7 million, net income $17.7 million, EPS EPS diluted were $0.03. Guidance reaffirmed.

“Inc. (NYSE: ANDG) today released financial results for the first quarter ended March 31, 2026. Andersen continued to deliver strong top-line growth with first-quarter revenue of $240.7 million up 15.7%, compared with $208.1 million in the prior year quarter. Higher revenue in the first quarter of 2026 was supported by client growth, higher volume and service line”

Atea Pharmaceuticals, Inc. reported financial results for for the first quarter ended March 31, 2026.

“On May 12, 2026, Atea Pharmaceuticals, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026”

Black Rock Coffee Bar, Inc. reported the first quarter ended March 31, 2026 results: revenue $55.5 million, net income $1.8 million. Guidance reaffirmed.

““Company”) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights • Opened 9 new stores during the period • Total revenue of $55.5 million, up 23.7% compared to the prior year period • Same Store Sales Growth (1) increased 5.2% compared to the prior year period • Income from operations of $2.7 million compared to”

ANAPTYSBIO, INC reported first quarter ended March 31, 2026 results: revenue Collaboration revenue was $25.6 million for the three months ended March 31, 2026, net income Net loss was $52.9 million for the three months ended March 31, 2026, or a net loss per share of $1.84, EPS net loss per share of $1.84.

“On May 12, 2026, AnaptysBio, Inc. (“AnaptysBio”) issued a press release announcing its financial results for the three months ended March 31, 2026.”

American Integrity Insurance Group, Inc. reported the first quarter of 2026 results: revenue $82.2 million, net income $19.9 million, EPS $1.02 per diluted share.

“of 23.7% , compared to 87.5% for the first quarter of 2025 . Adjusted return on equity 1 of 23.9% , compared to 87.4% in the first quarter of 2025 • Net premiums earned of $82.2 million , an increase of 25.7% compared to the first quarter of 2025 • Policies-in-force were 437,308 at March 31, 2026, up 14.1% over March 31, 2025 • Combined ratio of 75.0% in the”

INFINITY NATURAL RESOURCES, INC. reported the quarter ended March 31, 2026 results: net income narrowed net loss to $6.3 million, or $0.28 per share of Class A common stock.

“On May 12, 2026, Infinity Natural Resources, Inc. (the "Company") issued a press release announcing its financial and operating results for the quarter ended March 31, 2026.”

Karman Holdings Inc. reported first quarter fiscal year ended March 31 2026 results: revenue $151.2 million, net income $7.8 million, EPS $0.06. Guidance raised.

“to space , today reported first quarter fiscal year 2026 financial results. First Quarter Fiscal Year 2026 and subsequent highlights • Produced record quarterly revenue of $151.2 million, up 51.0% year over year • Generated record quarterly net income of $7.8 million and earnings per fully diluted share of $0.06, compared to a net loss of $4.8 million and loss”

QXO, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $1,730.2, net income $(227.1), EPS $(0.35).

“$(0.12) for the three months ended March 31, 2026. FIRST QUARTER 2026 SUMMARY RESULTS Three Months Ended March 31, (in millions, except for per share data) 2026 2025 Net sales $ 1,730.2 $ 13.5 Net (loss) income $ (227.1) $ 8.8 Net margin (13.1) % 65.2 % Adjusted EBITDA (1) $ 1.2 $ (9.0) Adjusted EBITDA Margin (1) 0.1 % (66.7) % Adjusted Net Loss (1) $ (57.2) N/M”

Tenon Medical, Inc. reported the first quarter ended March 31, 2026 results: revenue $1.4 million, net income $3.5 million, EPS $0.31 per share.

“PRESS RELEASE OF TENON MEDICAL, INC., DATED MAY 12, 2026 Exhibit 99.1 Tenon® Medical Reports First Quarter 2026 Financial Results ~ First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~ ~ First Quarter Gross Profit of $0.9 Million, an Increase of Approximately 193% Compared to Prior Year ~ ~ Gross Margin”

iBio, Inc. reported financial results for third quarter ended Mar. 31, 2026.

“On May 12, 2026, iBio, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”